(19)
(11) EP 2 686 011 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
04.10.2017 Bulletin 2017/40

(45) Mention of the grant of the patent:
30.08.2017 Bulletin 2017/35

(21) Application number: 12725287.2

(22) Date of filing: 14.03.2012
(51) International Patent Classification (IPC): 
A61K 39/12(2006.01)
(86) International application number:
PCT/NO2012/050040
(87) International publication number:
WO 2012/078051 (14.06.2012 Gazette 2012/24)

(54)

IPN VACCINE

IPN-IMPFSTOFF

VACCIN CONTRE LA NÉCROSE PANCRÉATIQUE INFECTIEUSE (IPN)


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 16.03.2011 NO 20110402
02.05.2011 NO 20110650

(43) Date of publication of application:
22.01.2014 Bulletin 2014/04

(73) Proprietor: Benchmark Animal Health Limited
Sheffield S35 1QN (GB)

(72) Inventors:
  • EVENSEN, Øystein
    N-0198 Oslo (NO)
  • RITCHIE, Gordon
    N-4085 Hundvåg (NO)
  • JØSSUND, Trude Bakke
    N-7745 Oppland (NO)
  • MUTOLOKI, Stephen
    N-0673 Oslo (NO)

(74) Representative: Mitchell, Simon James et al
Urquhart-Dykes & Lord LLP One Euston Square 40 Melton Street
London NW1 2FD
London NW1 2FD (GB)


(56) References cited: : 
WO-A2-99/50419
   
  • H. SONG ET AL: "Molecular Determinants of Infectious Pancreatic Necrosis Virus Virulence and Cell Culture Adaptation", JOURNAL OF VIROLOGY, vol. 79, no. 16, 15 August 2005 (2005-08-15), pages 10289-10299, XP55038140, ISSN: 0022-538X, DOI: 10.1128/JVI.79.16.10289-10299.2005
  • Orpetveit I, et al.: "Molecular epidemiology of infectious pancreatic necrosis virus (IPNV) in Norway", , 16 October 2008 (2008-10-16), XP007921040, Retrieved from the Internet: URL:http://www.fiskerifond.no/files/projec ts/attach/sluttrapport_165029_del_2.pdf [retrieved on 2012-09-13]
  • N M RUANE ET AL: "Molecular differentiation of infectious pancreatic necrosis virus isolates from farmed and wild salmonids in Ireland", JOURNAL OF FISH DISEASES, vol. 32, no. 12, 1 December 2009 (2009-12-01), pages 979-987, XP55038154, ISSN: 0140-7775, DOI: 10.1111/j.1365-2761.2009.01080.x
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).